1. Field of the Invention
The invention relates to an artificial airway device, more specifically to a supraglottic airway designed to have increased internal pressure during introduction of artificial positive-pressure ventilation.
2. Description of the Related Art
In general, supraglottic airways such as laryngeal masks allowing for both rapid lung ventilation and the insertion of medical instruments and tubes into the laryngeal openings of patients have been described in patents, such as U.S. Pat. No. 4,509,514 to Brain and U.S. Pat. Nos. 6,422,239 and 5,937,860 to Cook the entire disclosures of which were herein incorporated by reference. Laryngeal masks generally consist of two major components, a breathing tube and an inflatable or rigid shield, these devices are inserted into a patient's throat, and when properly positioned, cover the laryngeal opening. A seal is then formed around the circumference of the laryngeal opening by the inflation of a ring-like structure located toward the front of the mask (patient end). Inflation of the ring exerts pressure against the front, sides, and rear portions of the oropharynx, securing the device in place such that the laryngeal opening is positioned in alignment with a recessed cavity in the mask face. Alternatively, the structure of the shield may be formed as a large semi-rigid plastic construct which generally serves to seal by contouring to the shape of the throat and imparting pressure on the throat by its own size and shape effectively filing available space.
Extending from a point external to the oral cavity, the flexible breathing tube terminates within the recessed cavity, aligned axially with the laryngeal opening. The positioning of the flexible breathing tube allows the passage of endo-tracheal tubes or related medical instruments into the laryngeal opening, in addition to allowing for positive-pressure lung ventilation.
While current supraglottic airways such as laryngeal masks can provide for improved placement and breathing over a traditional endotracheal tube, they can be improved. In particular, the use of inflated structures or semi-rigid plastic constructs to hold the device in place in the throat can lead to undesirable pressure on throat tissue. Current designs seal the laryngeal opening inside the recess by exerting a constant pressure on surrounding tissue effectively forcing the structure of the mask into the walls of the throat while it is in place. This constant pressure is generally not relieved until the device is removed. While the structure of these devices are generally made pliable and soft so as to minimize potential damage from their near constant contact with throat tissues, the constant pressure they impart on potentially sensitive structures in the throat can, in some cases, lead to tissue fatigue and damage.
The problem is exacerbated by the fact that the person inserting the airway generally has little to no control on the pressure exerted by the airway and often has no indication thereof. Thus, the device can easily be accidentally over-inflated or over-sized exerting more pressure than is necessary or desirable on the tissue of the throat, often without realizing it.
The following is a summary of the invention in order to provide a basic understanding of some aspects of the invention. This summary is not intended to identify key or critical elements of the invention or to delineate the scope of the invention. The sole purpose of this section is to present some concepts of the invention in a simplified form as a prelude to the more detailed description that is presented later.
Because of these and other problems in the art, described herein is a supraglottic airway primarily intended to facilitate lung ventilation and the insertion of endo-tracheal tubes or related medical instruments into a patient's trachea as needed during general anesthesia, intensive care, critical patient care, or at any other time that ventilation would be desired. In an embodiment of such a supraglottic airway, the airway comprises a flexible ventilation tube and a positioning shield which is characterized as being “self-pressurizing.” This term refers to the fact that the shield generally imparts an increased sealing pressure on the throat when under positive pressure from assisted ventilation than it does during spontaneous exhalation. In this way the shield is generally only “pressurized” intermittently and only exerts its highest sealing pressure on throat tissues in a limited fashion. The shield generally conforms to the anatomy of the oropharynx region surrounding the laryngeal opening, and is securely affixed to the distal end of the ventilation tube.
Described herein, among other things is a supraglottic airway comprising; a respiratory tube having a distal end, a proximal end, and a length therebetween, the respiratory tube having a hollow interior; and a shield comprising a posterior base and a sealing ring surrounding the posterior base and defining an inner volume within the sealing ring and a cavity above the posterior base; wherein the shield is attached to the distal end of the respiratory tube so that the hollow interior of the respiratory tube is in fluid communication with the cavity; wherein the hollow interior and the cavity jointly define an air path; and wherein the inner volume of the sealing ring is capable of fluid communication with the air path.
In an embodiment of the airway the respiratory tube is smoothly curved and may comprise a connector removeably attached to the proximal end of the respiratory tube.
The airway may be constructed using any technique of manufacture such as, but not limited to, blow-molding or injection molding. The airway may be intended to be disposable, that is for single use, or may be intended for sterilization and reuse between patients.
In an embodiment of the airway the air path may be in fluid communication with the inner volume via a port. This port may be located in the respiratory tube in a side of the sealing ring opening into the cavity and may comprise a single hole, multiple holes, or an elongated, potentially continuous, slit which may circumscribe the cavity.
There is also described herein a supraglottic airway comprising; a respiratory tube having a distal end, a proximal end, and a length therebetween, the respiratory tube defining an air path therethrough; and a shield comprising a posterior base and a sealing ring surrounding the posterior base and defining an inner volume within the sealing ring and a cavity above the posterior base, wherein the shield is attached to the distal end of the respiratory tube so that the air path in the respiratory tube is in fluid communication with the cavity and wherein the cavity is in fluid communication with an inner volume of the sealing ring.
There is also described herein, a supraglottic airway comprising; a respiratory tube having a distal end, a proximal end, and a length therebetween, the respiratory tube defining an air path therethrough; and a shield comprising a posterior base and a sealing ring surrounding the posterior base and defining an inner volume within the sealing ring, wherein the shield is attached to the distal end of the respiratory tube so that the air path in the respiratory tube is in fluid communication with the inner volume of the sealing ring.
There is also described herein a method of providing an artificial airway to a human comprising: placing in the throat of a human, a supraglottic airway comprising; a respiratory tube having a distal end, a proximal end, and a length therebetween, the respiratory tube defining a hollow interior; and a shield comprising a posterior base and a sealing ring surrounding the posterior base and defining an inner volume within the sealing ring and a cavity above the posterior base, wherein the shield is attached to the distal end of the respiratory tube and the cavity and the hollow interior jointly define an air path; attaching the proximal end to a ventilation apparatus; and forcing air into the air path to provide air to the patient; wherein, the act of forcing air into the air path alters the pressure in the inner volume of the sealing ring.
Depending on the embodiment of the method the alteration of pressure in the inner volume of the sealing ring may alter the size of the sealing ring as air is forced into the air path, increase the strength of seal of the sealing ring to the throat or increase the pressure the sealing ring imparts on the throat.
There is still further described herein, an artificial breathing system comprising: a supraglottic airway including; a respiratory tube having a distal end, a proximal end, and a length therebetween, the respiratory tube defining a hollow interior therethrough; and a shield comprising a posterior base and a sealing ring surrounding the posterior base and defining an inner volume within the sealing ring and a cavity above the posterior base, wherein the shield is attached to the distal end of the respiratory tube and the cavity and the hollow interior jointly define an air path; and a ventilation apparatus designed to increase pressure in the air path which is attached to the proximal end; wherein, when the ventilation apparatus increases pressure in the air path it also alters the pressure in the inner volume in the sealing ring.
Depending on the embodiment of the system the alteration of pressure in the inner volume of the sealing ring may alter the size of the sealing ring as air is forced into the air path, increase the strength of seal of the sealing ring to the throat or increase the pressure the sealing ring imparts on the throat.
In an embodiment of the system, there is a port interconnecting the inner volume of the sealing ring to at least one of the cavity or the hollow interior, the port allowing the alteration in the pressure of the sealing ring. This port may be located in the respiratory tube in a side of the sealing ring opening into the cavity and may comprise a single hole, multiple holes, or an elongated, potentially continuous, slit which may circumscribe the cavity.
There is still further described herein, a supraglottic airway comprising; a respiratory tube having a distal end, a proximal end, and a length therebetween, the respiratory tube having a hollow interior; a shield comprising a posterior base and a sealing ring surrounding the posterior base and defining a cavity above the posterior base; and means for allowing fluid communication between an inner volume of the sealing ring and at least one of the cavity or the hollow interior of the respiratory tube.
The following detailed description illustrates by way of example and not by way of limitation. Described herein, among other things, is an embodiment of a supraglottic airway which includes a shield for sealing with the larynx which is designed to exert greater pressure, and therefore a stronger seal, when an assisted inhalation is being provided for the patient during positive-pressure ventilation. Specifically, the supraglottic airway has a shield (201) including a sealing ring (401). The ring (401) is in gaseous (or more generally fluid) communication with the airway path through which artificial respiration air is provided to the patient. While the supraglottic airway described herein incorporates certain features in the shape and arrangement of the shield (201) for improved placement in the airway, it should be recognized that these features are not required and the sealing rings (401) and related structures discussed herein can be used on airways of other shapes and forms.
In the depicted embodiment of
The positioning shield (201) comprises a generally wedge-shaped flexible sealing ring (401) with a pliable molded posterior base (403) attached thereto so that the posterior base (403) forms the base of, and the sealing ring (401) generally surrounds, a cavity (511). The sealing ring (401) is also generally sized and shaped to generally conform to the approximate available space in the oropharynx region without significant distortion or causing significant displacement of throat surfaces. Depending on embodiment, the sealing ring (401) may comprise a number of different structures and may be ellipsoidal, toroidal, or of similar shape. As shown in
The posterior base (403) is secured longitudinally within a space in the center of the sealing ring (401) to form cavity (511). The posterior base (403) is generally attached in a fashion to form an elongated and tapered hemisphere relative the generally major plane of the sealing ring (401) so as to give the shield (201) an overall shape such as that seen in the FIGS. In the depicted embodiment, there are semi-rigid raised ridges (409) positioned longitudinally parallel to each other along the surface (413) of the posterior base (403) “inside” the space of the sealing ring (401). This space above the posterior base (403) and “inside” the sealing ring (401) is defined herein as a cavity (511).
The sealing ring (401) may comprise a number of different shapes or structures but will generally comprise a section extending upward from the posterior base (403) so as to form the cavity (511) in the shield (201). The sealing ring (401) is generally constructed of a flexible material which is capable of being moved when placed under the influence of air pressure on the order of that expected during positive-pressure ventilation of a patient. This movement will be characterized as expansion, which may comprise inflation such as in a balloon, or may be a shifting or movement of various structures to have a generally larger displacement. An embodiment of the expansion of a sealing ring (401) is shown in
In the embodiments of
The shield (201) in the depicted embodiment of
The wedge (501) therefore gives an access into the cavity (511) from the interior of the respiratory tube (205) allowing air to pass from the cavity (511) into the distal end (203) of the respiratory tube (205) and from there out the proximal end (207) of the respiratory tube (205) or vice-versa. The wedge (501) is generally formed into an angle (521) to the length of the respiratory tube (205) which is generally between 0 and 90 degrees and preferably about 30 to about 35 degrees with the posterior base (403), forming an elongated elliptically shaped distal lumen (523) open to the interior of the cavity (511) and interior of the respiratory tube (205).
There may also be included a ventilation lumen (531) through the wedge (501) to provide an alternate airway passage in the event the distal lumen (523) becomes obstructed during patient lung ventilation. The ventilation lumen (531) also generally prevents the formation of a pressure differential between the cavity (511) and flexible respiratory tube (205). Absent a pressure differential, any object obstructing the distal lumen (523) will not generally become inextricably lodged.
In order to provide that air introduced into the airway (100) for use by the patient be able to pressurize the sealing ring (401), there is provided a fluid communication port (452) which allows for fluid (particularly gas in the form of ventilated air) to pass from the air path to the interior of the sealing ring (401). This fluid communication port (452) may be located anywhere in the air path providing access to the inner volume (412) of the sealing ring (401). In the embodiment of
The respiratory tube (205) may be formed in any manner known to those of ordinary skill in the art but will generally form a smoothly curving hollow cylinder of generally circular or elliptical cross-section preferably approximating, for ease of insertion, the shape of the human throat. The respiratory tube (205) is preferably sized and shaped to accommodate the passage of endo-tracheal tubes and related medical devices up to 9 French in diameter. The length of respiratory tube (205) is such that when the laryngeal mask (100) is properly positioned for use within the oropharynx, the attachment (proximal) end (207) of respiratory tube (205) is located exterior to the oral cavity of the patient. The attachment end (207) of the respiratory tube (205) terminates in an unobstructed proximal lumen (209), providing a direct pathway through the respiratory tube (205) to the distal end (203) and distal lumen (523). In alternative embodiments, the attachment end (207) may be fitted with removable adapters or connectors (871) suitable for connection to a variety of medical devices, for example, lung ventilation machines.
As shown in
The sealing is best understood in conjunction with
The example of expansion shown in
As the seal pressure increases, so does the ability of the shield (201) to maintain the internal airflow from the ventilation apparatus directing additional air into the lungs of the patient. Once the lungs have been appropriately inflated, exhalation generally occurs by having the patient spontaneously breath out. Air escaping the patient's lungs will generally pass back from the lungs through the respiratory tube (205) and escape the patient. During exhalation, however, it is generally not necessary that the shield (201) be tightly sealed. If air was to escape the shield (201) by going around it, this air would still generally pass out of the mouth of the patient.
By allowing the shield (201) to self-pressurize when air pressure inside the airway (100) is increased by air being forced into the patient's lungs during assisted inhalation, and a decrease of the pressure during exhalation, the airway (100) significantly reduces the pressure placed on the throat (945) during the course of use of the airway (100). In particular, it is understood in the art that generally exhalation takes twice as long as inhalation, therefore the time that the throat is subject to the increased sealing pressure from the pressurized shield (201) is generally reduced by about two-thirds since the airway (100) is pressurized an increased amount only during inhalation. This can significantly reduce the potential for damage to pressure sensitive structures in the throat by simply reducing the amount of time, in any procedure, the structures are exposed to the increased pressure.
Further, the self-pressurization provides for some controlled monitoring of the pressure placed on the structures in the throat contacted by the shield (201). It is understood that when pressurizing the lungs of a patient during assisted inhalation, peak pressures should generally not be maintained above the range of about 60 cm of water as this can result in damage to the lungs. Pressures are generally maintained in the 15 to 30 cm of water range. For this reason, squeeze bags and other ventilation systems are generally inhibited from producing damaging pressure by their design and/or operation. It is also generally the understanding of the art that similar pressure ranges to those which are safe for lung inflation are also within a safe zone for inhibiting damage to throat structures. As the pressure inside the shield (201) is effectively limited to the maximum pressure provided by the attached ventilation apparatus, and since the ventilation apparatus is provided with a safe zone for lung ventilation which is believed inside the safe zone for throat damage, both body structures are simultaneously protected.
As should be apparent from the above discussion, the self-pressurization of the sealing ring (401) occurs by having the sealing ring (401) be in fluid communication with the air path (454) in such a fashion that when air is directed into the air path (454), there is an air pressure differential created inside the shield (201) which allows air to flow into inner volume (412) of the sealing ring (401) providing for pressurization of the flexible structures of the sealing ring (401) to expand and increase the contact pressure between the throat and the sealing ring (401).
In the embodiment of
One of ordinary skill in the art would see that the three depicted embodiments are not the only possible structures which would allow for fluid communication from the air path to the sealing ring (401). In an additional alternative embodiment, the port (452) could be replaced by alternative structures allowing fluid communication.
The airway (100), in an embodiment, may be constructed from a single blow-molded or injection molded construction which is formed into both the shield (201) and respiratory tube (205) by blowing or injecting suitable construction materials such as plastics or silicone into a shaped die. In such an embodiment, the entire airway (100) may be formed as a single piece. Often to facilitate such construction, the ventilation lumen (531) and distal lumen (533) would be sealed in the initial formation. The lumens (531) and (533) would then be punched or cut out from resultant structure to create the openings. The embodiment of
Blow-molding techniques generally require that the structure to be formed comprise a hollow balloon which is then pushed or molded into shape.
As can be further seen in
In an embodiment where the airway (100) is comprised of two pieces, in order to assemble the embodiment of airway (100) shown in
The respiratory tube (205) is now inserted, proximal end (207) first, through the hole (709), passed through the sealing ring (401), and extended out the entry point (462) and thus the posterior end (505) of the shield (201). The hole (709) and entry point (462) are preferably sized and shaped to be of relatively similar size to the exterior diameter of the respiratory tube (205) so that a tight connection is formed by the respiratory tube (205) distending the material of the shield (201) slightly in both places. The respiratory tube (205) will continue to be slid through the hole (709) and entry point (462) until the hole (709) interacts with the groove (551) and disk (553). At that point, the wedge (501) and disk (553) will generally be the only portions of the respiratory tube (205) which has not passed through the hole (709), the reinforced support (525) will be adjacent to the recess (435) in the posterior base (403), and the fluid communication port (452) is internal to the sealing ring (401) allowing air in the respiratory tube (205) to flow into the sealing ring (401). These pieces will then be connected together resulting in the wedge (501) being positioned in the cavity (511) and generally flush with the interior of the posterior base (403). The connection between the posterior base (403) and the reinforced support (525) may be formed in any manner known to one of ordinary skill in the art, however, in a preferred embodiment, the two devices are adhered together with a generally non-separable adhesive. The respiratory tube (205) now is arranged to generally pass through the sealing ring (401) allowing air flow from the respiratory tube (205) into both the interior of the sealing ring (401) and the cavity (511).
In the depicted embodiment, the disk (553) and groove (551) formed toward the distal end (203) of the respiratory tube (205) serve to reinforce the connection (703). In particular, the material surrounding the hole (709) will end up being stretched by the passing of the respiratory tube (205) until the hole (709) is aligned with the groove (551). The material will then relax and the hole (709) will collapse slightly into the groove (551). This provides a first level of support. The disk (553) adjacent to the hole (709) can then be provided with an adhesive which adheres to the shield (201).
While in the above embodiment, as depicted in
Generally, use of the airway (100) would proceed as follows. Before insertion, the sealing ring (401) would be in a neutral position, generally at an ambient internal pressure, and there would be little or no positive pressure created within the air path (454). The mouth of the patient is opened and their head positioned for insertion of the airway (100). The shield (201) is pushed into the orolaryngeal region. The smooth arcuate curves of the combined respiratory tube (205) and shield (201) positions the laryngeal mask (100) in alignment with the laryngeal opening (741). Upon proper positioning, as generally determined by a resistance to further forward motion, the airway (100) is considered placed. A breathing device or machine, such as a ventilator or a squeeze bag (951) would then be coupled to the attachment end (207) of the respiratory tube (205).
Positioned within the cavity (511), the distal lumen (523) is axially aligned with the laryngeal opening (941), permitting positive-pressure lung ventilation to be performed through the airway (100), or allowing endo-tracheal tubes or related medical instruments inserted through the respiratory tube (205) to exit through the distal lumen (523) which is directly aligned for passage into the laryngeal opening (941). Removal of the airway (100) is normally the reverse of the insertion procedure described above. As the device is generally relatively inexpensive to manufacture, once it has been removed the airway (100) will generally be discarded. However, in an alternative embodiment it may be sterilized and reused in any manner understood by those of ordinary skill in the art.
During assisted positive-pressure ventilation, the airway (100) would operate as follows. When a breath is provided for the patient, the ventilator or other device would be used to increase air pressure inside the respiratory tube (205) forcing air into the tube (205) and toward the cavity (511). As the air pressure increases along the tube (205) and/or cavity (511), some of the air being pressed toward the patient will enter the port (452) and flow into the sealing ring (401), while other air will continue to flow out the wedge (501) and into the cavity (511) and the trachea (943) and lungs of the patient. The pressure of air flowing into the lungs, and the pressure of air flowing into the sealing ring (401) will generally be relatively equal. As there is generally no external escape for the air in the air path, the sealing ring (401) will generally pressurize causing it to seal tighter within the throat (945). This will force the airway (100) into stronger contact with the walls of the throat (945) and surface (951). As the shield (201) and throat (945) are pressed together, they will form a stronger seal and will inhibit air from inside the cavity (511) from passing between them, instead directing that air into the lungs of the patient. This process will continue as long as air is under positive pressure and directed toward the lungs by the ventilation apparatus.
Once the inhalation is complete, the pressure will generally be decreased inside the air path (454). This will result in the pressure in the air path (454) decreasing back toward ambient and the sealing ring (401) decreasing the pressure imparted by the airway (100) to the throat (945). As the patient begins to exhale (generally by spontaneous exhalation), the patient will push air back toward the airway (100). This air will generally pass into the cavity (511) and then flow out into the respiratory tube (205) and escape the patient's body. Some of such air may pass into the sealing ring (401) and serve to increase the pressure slightly, but this will generally result in a pressure between the sealing ring (401) and the throat (945) still being significantly less than that during the assisted inhalation Alternatively, some air may escape around the edges of the shield (201). As the pressure of spontaneous exhalation is generally insufficient to result in opening of the esophageal sphincter, this air will generally escape around the airway (100) and exit the patient through their mouth or nose. Once exhalation is complete, the process will generally repeat beginning with another inhalation.
The elimination of the need to tightly seal the shield (201) during exhalation with as much pressure as during inhalation relates in part to the expected behavior of air during inhalation and exhalation. It is undesirable for air, during forced inhalation to be able to proceed down the esophagus. At sufficient pressure to inflate the lungs there is also generally sufficient pressure to open the esophageal sphincter and allow air to enter into the stomach. Forcing air into the stomach can create a potentially dangerous situation. Therefore, during this forced inhalation, it is desirable that the shield (201) seal strongly so as to provide an air passage into the laryngeal opening (941) without allowing the pressurized input air to escape into the stomach. The airway (100) carries out this task since the tightness and inflation of the sealing ring (401) to the throat (945) increases proportionate to the force of air within the passageway. As the air pressure increases in the passageway (approaching levels where air could be forced in the stomach), the sealing ring (401) inflates and improves the tightness of its seal to the throat (945), inhibiting air from passing outside of the air passage and directing that air into the lungs.
During spontaneous exhalation, the pressure produced by the patient's lungs is generally insufficient to force air past the esophageal sphincter, and thus there is a decreased need for the airway (100) to be tightly sealed to the laryngeal opening (941). While it is expected that most air will in fact flow out the respiratory tube (205) as the path of least resistance, even if it does not, the air which escapes will have insufficient force to push past the esophageal sphincter and will instead escape around the airway (100) and out the mouth or nose as in normal breathing.
While the invention has been disclosed in connection with certain preferred embodiments, this should not be taken as a limitation to all of the provided details. Modifications and variations of the described embodiments may be made without departing from the spirit and scope of the invention, and other embodiments should be understood to be encompassed in the present disclosure as would be understood by those of ordinary skill in the art.
This application is a Continuation of U.S. Utility patent application Ser. No. 11/747,486, filed May 11, 2007 now U.S. Pat. No. 7,934,502, the entire disclosure of which is herein incorporated by reference.
Number | Name | Date | Kind |
---|---|---|---|
678814 | Riggs | Jul 1901 | A |
1345425 | Wells | Jul 1920 | A |
2335741 | Contaldi | Nov 1943 | A |
2787010 | Uphoff | Apr 1957 | A |
3139088 | Galleher, Jr. | Jun 1964 | A |
3434100 | Dykzeul | Mar 1969 | A |
3606669 | Kemble | Sep 1971 | A |
3734100 | Walker et al. | May 1973 | A |
3756601 | Frey et al. | Sep 1973 | A |
3945069 | Cecil | Mar 1976 | A |
4146034 | Gupta | Mar 1979 | A |
4231365 | Scarberry | Nov 1980 | A |
4327720 | Bronson et al. | May 1982 | A |
4340046 | Cox | Jul 1982 | A |
4388076 | Waters | Jun 1983 | A |
4444201 | Itoh | Apr 1984 | A |
4509512 | LeClercq | Apr 1985 | A |
4509514 | Brain | Apr 1985 | A |
4520810 | Weiss | Jun 1985 | A |
RE31948 | Deutsch et al. | Jul 1985 | E |
4540959 | Saad | Sep 1985 | A |
4582056 | McCorkle, Jr. | Apr 1986 | A |
4593687 | Gray | Jun 1986 | A |
4661028 | Sanger | Apr 1987 | A |
4674496 | Svadjian et al. | Jun 1987 | A |
4751922 | DiPietropolo | Jun 1988 | A |
4791923 | Shapiro | Dec 1988 | A |
4825861 | Koss | May 1989 | A |
4863439 | Sanderson | Sep 1989 | A |
4872483 | Shah | Oct 1989 | A |
4895533 | Yagi et al. | Jan 1990 | A |
4919127 | Pell | Apr 1990 | A |
4995388 | Brain | Feb 1991 | A |
5024220 | Holmgreen et al. | Jun 1991 | A |
5033919 | Choe | Jul 1991 | A |
5037251 | Roth | Aug 1991 | A |
5042475 | LaBombard | Aug 1991 | A |
5071413 | Utterberg | Dec 1991 | A |
5197463 | Jeshuran | Mar 1993 | A |
5218970 | Turnbull et al. | Jun 1993 | A |
5222487 | Carr et al. | Jun 1993 | A |
5253658 | King | Oct 1993 | A |
5277178 | Dingley | Jan 1994 | A |
5279610 | Park et al. | Jan 1994 | A |
5282464 | Brain | Feb 1994 | A |
5303697 | Brain | Apr 1994 | A |
5324080 | McNaughton et al. | Jun 1994 | A |
5326196 | Noll | Jul 1994 | A |
5340165 | Sheppard | Aug 1994 | A |
5355879 | Brain | Oct 1994 | A |
5391248 | Brain | Feb 1995 | A |
5392774 | Sato | Feb 1995 | A |
5393101 | Matkovich | Feb 1995 | A |
5477852 | Landis et al. | Dec 1995 | A |
5509408 | Kurtis | Apr 1996 | A |
5513627 | Flam | May 1996 | A |
5527316 | Stone et al. | Jun 1996 | A |
5529582 | Fukuhara | Jun 1996 | A |
5545048 | Maeda | Aug 1996 | A |
5546937 | Stuart et al. | Aug 1996 | A |
5562371 | Reed | Oct 1996 | A |
5562673 | Koblish et al. | Oct 1996 | A |
5569222 | Haselhorst et al. | Oct 1996 | A |
5579762 | Lee | Dec 1996 | A |
5584290 | Brain | Dec 1996 | A |
5588424 | Insler et al. | Dec 1996 | A |
5590643 | Flam | Jan 1997 | A |
5623921 | Kinsinger et al. | Apr 1997 | A |
5632271 | Brain | May 1997 | A |
5643174 | Yamamoto et al. | Jul 1997 | A |
5653231 | Bell | Aug 1997 | A |
5655519 | Alfery | Aug 1997 | A |
5682880 | Brain | Nov 1997 | A |
5711296 | Kolobow | Jan 1998 | A |
5713348 | Pell | Feb 1998 | A |
5720749 | Rupp | Feb 1998 | A |
5743258 | Sato et al. | Apr 1998 | A |
5772643 | Howell et al. | Jun 1998 | A |
5787879 | Gibson | Aug 1998 | A |
5878745 | Brain | Mar 1999 | A |
5881726 | Neame | Mar 1999 | A |
5896858 | Brain | Apr 1999 | A |
5937860 | Cook | Aug 1999 | A |
5947120 | Bailey | Sep 1999 | A |
5961489 | Hirota | Oct 1999 | A |
5979445 | Neame et al. | Nov 1999 | A |
6021779 | Pagan | Feb 2000 | A |
6196224 | Alfery | Mar 2001 | B1 |
6240922 | Pagan | Jun 2001 | B1 |
6261404 | Baska et al. | Jul 2001 | B1 |
6374827 | Bowden et al. | Apr 2002 | B1 |
6386199 | Alfery | May 2002 | B1 |
6422239 | Cook | Jul 2002 | B1 |
6450164 | Banner et al. | Sep 2002 | B1 |
6612305 | Fauza | Sep 2003 | B2 |
6631720 | Brain | Oct 2003 | B1 |
6668821 | Christopher | Dec 2003 | B2 |
6705318 | Brain | Mar 2004 | B1 |
6705320 | Anderson | Mar 2004 | B1 |
6705321 | Cook | Mar 2004 | B2 |
6705322 | Chang | Mar 2004 | B2 |
6729325 | Alfery | May 2004 | B2 |
6892731 | Cook | May 2005 | B2 |
6899147 | Ogawa et al. | May 2005 | B2 |
6923176 | Ranzinger | Aug 2005 | B2 |
6935153 | Frigo et al. | Aug 2005 | B2 |
6983744 | Alfery | Jan 2006 | B2 |
7013899 | Alfery et al. | Mar 2006 | B2 |
7021686 | Glasgow et al. | Apr 2006 | B2 |
7040312 | Alfery et al. | May 2006 | B2 |
7040322 | Fortuna | May 2006 | B2 |
7096868 | Tateo et al. | Aug 2006 | B2 |
7097802 | Brain | Aug 2006 | B2 |
7128071 | Brain | Oct 2006 | B2 |
7305985 | Brain | Dec 2007 | B2 |
7934502 | Cook | May 2011 | B2 |
20010050082 | Christopher | Dec 2001 | A1 |
20030051734 | Brain | Mar 2003 | A1 |
20040020491 | Fortuna | Feb 2004 | A1 |
20040079364 | Christopher | Apr 2004 | A1 |
20050016529 | Cook | Jan 2005 | A1 |
20050051173 | Brain | Mar 2005 | A1 |
20050139220 | Christopher | Jun 2005 | A1 |
20060027238 | Lin | Feb 2006 | A1 |
20060076021 | Chang | Apr 2006 | A1 |
20060180156 | Baska | Aug 2006 | A1 |
20060207597 | Wright | Sep 2006 | A1 |
20070028923 | Souris et al. | Feb 2007 | A1 |
20070102001 | Brain | May 2007 | A1 |
20070137651 | Glassenberg et al. | Jun 2007 | A1 |
20070246050 | Parikh et al. | Oct 2007 | A1 |
20080078398 | Cook | Apr 2008 | A1 |
Number | Date | Country |
---|---|---|
10-263084 | Oct 1998 | JP |
2003-210585 | Jul 2003 | JP |
Entry |
---|
“Products—LMA Fastrach,” http://www.lmana.com/prod/components/products/lma—fastrach.html, printed on Jun. 19, 2005, one page. |
“9c Removal of LMA-Fastrach Prior to Extubation,” LMA-Fastrach Instructional Manual, www.lmana.com/docs/fastrach—instruction.pdf, Feb. 2002, pp. cover (2 pages), 26-27. |
Byrd, Jr., R.P.“Ventilation, Mechanical,” http://www.emedicine.com/med/topic3370.htm, Jul. 6, 2006, pp. 1-13. |
“Ambu Product Information,” Ambu A/S, Denmark, 2007, pp. 1-18. |
“Intersurgical Complete Respiratory Systems,” http://www.intersurgical.com/productscatalog/choosegroup.aspx?cm . . . , printed on Apr. 11, 2007, one page. |
“LMA Airway Instruction Manual,” The Laryngeal Mask Company Limited, www.lmana.com/docs/LMA—Airways—Manual.pdf, 2005, pp. 1-23. |
International Search Report, International Patent Application No. PCT/US2008/060425, mailed Sep. 29, 2008, 11 pages. |
Number | Date | Country | |
---|---|---|---|
20110168183 A1 | Jul 2011 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11747486 | May 2007 | US |
Child | 13073644 | US |